Dihexa for Women: What the Research Has Looked At, and What to Check First

The 2013 paper in the Journal of Pharmacology and Experimental Therapeutics that introduced Dihexa reported that, by mouth or by injection, it improved performance in the Morris water maze, a swimming task that measures spatial memory, in rats whose memory had been impaired with scopolamine and in aged rats. That paper carries a 2021 expression of concern. The strongest independent result is a 2021 paper in Brain Sciences, from a separate group, which reported improved memory-task performance in APP/PS1 mice, a strain engineered to accumulate amyloid plaques, alongside increased PI3K/Akt signalling.

What it shows. That a few labs have reported memory-task effects in rodent models of impairment.

What it does not show. Anything in people, of either sex. The live research describes no separate findings for females or males, and no study has tested Dihexa in healthy adults with ordinary complaints about recall.

The developers proposed that Dihexa works by binding hepatocyte growth factor (HGF) and making it a stronger activator of its receptor, c-Met. The two laboratory papers carrying that claim, from 2012 and 2014, received expressions of concern in 2021 and were retracted in April 2025. HGF/c-Met should be treated as the developing lab's hypothesis rather than an established finding. The same retracted 2014 paper is the source of the "forms new connections" claim about dendritic spines.

None. That is a thinner position than most compounded peptides. It is prescribed on mechanism plus a physician's judgement about a particular patient, and the fair description is "studied in animals," not "shown to work."

Fatigue, hair shedding, cold intolerance, brain fog and low mood are the classic presentation of iron deficiency and of an underactive thyroid, both far more common in women than in men: iron deficiency because of menstrual blood loss, and thyroid disease because autoimmune thyroiditis is heavily skewed toward women. Ferritin can be low while a full blood count reads normal, and a ferritin at the floor of the normal range is the classic result that is technically normal and practically the answer. B12 deficiency produces fog with tingling and balance changes, and is common on metformin, acid suppressants and vegetarian diets. None of these responds to Dihexa, and each is inexpensive to find.

The order a physician works through is in peptides for brain fog and focus and peptides for women. New or worsening memory problems in any adult need a proper work-up, and a diagnosed or suspected dementia belongs with a neurologist. Dihexa is not a treatment for Alzheimer's disease or any memory disorder.

Fog during the menopausal transition is often driven by sleep disruption, thyroid disease or iron deficiency, and those should be excluded first. Dihexa is not hormone therapy, does not act on the hormones that change, and has not been tested for any menopause symptom, including memory or concentration. If the transition is the driver, it belongs in the conversation with your physician rather than being treated around. Pepti does not prescribe menopausal hormone therapy. The wider picture is in peptides for menopause.

There is no human safety data of any kind for Dihexa, so there is none for pregnancy or lactation. It is not used in either situation. If you are pregnant, trying to conceive or think you may be, tell your physician before starting; if you become pregnant on treatment, stop and contact them the same day. See can you take peptides while pregnant and do peptides affect fertility.

This is the consideration most specific to Dihexa. HGF/c-Met is a proliferation pathway, and c-Met over-activity is a feature of many cancers. No study has shown Dihexa causes or speeds a tumour, and no human safety data exists to rule the concern in or out. A personal or strong family history of breast, ovarian, endometrial or any other cancer goes on the intake in full, and many physicians will not prescribe Dihexa in that situation. More in can peptides cause cancer.

Dihexa is not a hormone and is not described as acting on the cycle, hormonal contraception or menopausal hormone therapy. No study has looked at any of those directly, so list them on your intake, and report any cycle change on treatment even if another cause is the likelier explanation.

There is no established interaction list, because the trials that would produce one have not been run. Dihexa's parent fragment comes from the same hormone family that many blood-pressure medicines act on; no interaction has been studied, which is a reason to list every medication on your intake rather than a reason for alarm.

The 2026 WADA Prohibited List does not name Dihexa. Women who compete in a tested sport should still check with their anti-doping body before starting anything.